Hemophilia C
| Hemophilia C | |
| ICD-10 | D68.1 |
|---|---|
| ICD-9 | 286.2 |
| OMIM | 264900 |
| DiseasesDB | 29376 |
| eMedicine | ped/964 med/3515 |
| MeSH | D005173 |
|
WikiDoc Resources for Hemophilia C |
|
Articles |
|---|
|
Most recent articles on Hemophilia C Most cited articles on Hemophilia C |
|
Media |
|
Powerpoint slides on Hemophilia C |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Hemophilia C at Clinical Trials.gov Clinical Trials on Hemophilia C at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Hemophilia C
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Hemophilia C Discussion groups on Hemophilia C Patient Handouts on Hemophilia C Directions to Hospitals Treating Hemophilia C Risk calculators and risk factors for Hemophilia C
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Hemophilia C |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Hemophilia C is a mild form of haemophilia affecting both sexes. However, it predominantly occurs in Jews of Ashkenazi descent. It is the fourth most common coagulation disorder after von Willebrand's disease and haemophilia A and B.[1] In the USA it is thought to affect 1 in 100,000 of the adult population, making it 10% less common than haemophillia A. [2]
It is caused by a deficiency of coagulation factor XI and is distinguished from haemophilia A and B by the fact it does not lead to bleeding into the joints. Furthermore, it has autosomal recessive inheritance, since the gene for factor XI is located on chromosome 4 (close to the prekallikrein gene). Many mutations exist, and the bleeding risk is not always influenced by the severity of the deficiency. Treatment is usually not necessary, except in relation to operations, leading to many of those having the condition not being aware of it. In these cases, fresh frozen plasma or recombinant factor XI may be used, but only if necessary. The afflicted may often suffer nosebleeds, and females can experience heavy menstrual bleeding.[3] Hemophaelia C was first discovered in a young Ashkenazic Jewish American in the 1950s.
Symptoms
The symptoms of Haemophilia C are the same as those for other forms of Haemophilia, mainly:[4]
- Prolonged bleeding from injuries.
- Frequent or heavy nosebleeds.
- Traces of blood in the urine.